Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome-drug-host triad.
Journal: Frontiers in pharmacology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Strilić D, Stanimirov B, Pavlović N, et al. (2026). "Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome-drug-host triad.". Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1831882